ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 108 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $780,061 | +97.3% | 78,556 | +38.3% | 0.00% | +50.0% |
| Q4 2022 | $395,460 | +107.0% | 56,819 | +59.0% | 0.00% | +100.0% |
| Q3 2022 | $191,000 | +148.1% | 35,728 | +84.0% | 0.00% | 0.0% |
| Q2 2022 | $77,000 | -79.8% | 19,415 | -55.3% | 0.00% | -80.0% |
| Q3 2021 | $382,000 | -30.4% | 43,459 | -10.4% | 0.01% | -16.7% |
| Q2 2021 | $549,000 | -19.6% | 48,498 | -15.7% | 0.01% | -45.5% |
| Q1 2021 | $683,000 | -34.6% | 57,502 | -62.2% | 0.01% | -26.7% |
| Q4 2020 | $1,044,000 | +221.2% | 152,189 | +246.8% | 0.02% | +200.0% |
| Q3 2020 | $325,000 | +277.9% | 43,886 | +112.7% | 0.01% | +400.0% |
| Q2 2020 | $86,000 | – | 20,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |